Seminars
Instructions for accessing video links:
1) Click on the link, your default Internet browser should open.
2) If prompted by “There is a problem with this website’s security certificate,” please click on “Continue to this Website (not recommend).” *
3) If you are not able to view the video, please email avs@moffitt.org. Please allow one business day to respond.
* The site is safe. We are working to resolve the security certificate issue. If you have any questions, please use the email link above.
2011
6/16
Mun Ju Kim,Ph.D., University of Pittsburgh (IMO Post Doc Candidate) Computational Models of T-Cell Killing Apparatus Aim Adjustment
Will be rescheduled:
Kevin Brindle,Ph.D., University of Cambridge, Imaging Biology In The Cancer Patient - New Ways To Detect Treatment Response
Jack Tuszynski,Ph.D., University of Alberta, Canada TBA
Previous IMO Weekly Seminars
5/16
Marcus Owen, Ph.D., The University of Nottingham Mathematical Modeling Predicts Synergistic Benefits of Combining a Macrophage-Based Therapy with Chemotherapy
5/12
Steven A. Eschrich, Ph.D. , Moffitt Genes, Proteins and Networks: Molecular Analysis in Translational Research
5/5
David Axelrod,Ph.D., Rutgers University Stem Cell Dynamics in NOrmal Human Colon Crypts and the Progression to Colon Cancer PS-OC/IMO Seminar
4/22
Timothy W. Secomb,Ph.D., University of Arizona Growth and Structural Adaptation of Microciculation in Normal and Tumor Tissues PS-OC/IMO Seminar
4/7
Leonid A. Mirny,Ph.D., M.I.T. On Drivers and Passengers: A New Evolutionary Model of Cancer Progression PS-OC/IMO Seminar
3/24
Steve S. Brem, M.D., Moffitt Developing Treatments of Malignant Gliomas Using Inhibitors of Angiogenesis and Invasion: Potential Rose for Integrated Mathematical Modeling
3/7
Heiko Enderling, Ph.D. Tufts University School of Medicine Modeling the Cancer Stem Cell Hypothesis and Implications for Treatment IMO-PSOC Seminar
2/24
Alvaro Monteiro, Ph.D., Moffitt Probing the DNA Damage Response Using Networks
2/14
Eric A Mellon, Ph.D., University of Pennsylvania In Vivo NMR Spectroscopy of dfficult to detect metabolites
2/3
Conor Lynch,Ph.D., Moffitt Mechanisms of Cell-Cell Interaction in the Metastatic Prostate-Tumor Bone Microenvironment
1/27
Paul Orlando, The University of Illinois at Chicago Evolutionary Ecology of HPV: Tradeoffs, Co-Existence, and Species Origins of High-Risked and Low-Risk Types IMO-PSOC Seminar
2010
12/9 Srikumar Chellappan, Ph.D.,;Moffitt, Novels Insights into Lung Cancer Stem-Like Cells, Angiogenesis and Metastasis
11/18 Prakash Chinnaiyan, M.D.,;Moffitt, Targeting the Unfolded Protein Response (UPR) in Cancer: A Common Denominator of Unregulated Cellular Growth
10/25 Timothy Newman, Ph.D.,;Arizona State University, Cancer Is Complex - But Is It Simple? IMO-PSOC Seminar
10/14 Michael Tomblyn, M.D., MS,;Moffitt, Dosimetric Challenges for Delivery of Intrathecal Radioim
10/7 Jill Gallaher,Ph.D., IMO Post Doc Candidate, Pore Kinetics of Pure Lipid Bilayer Membranes at the Melting Transition
9/23 Shengyu Yang, Ph.D., Moffitt, Critical Roles of Actin Cytoskeleton in Cancer Metastasis
9/20 Hongfei Wu,Ph.D., IMO Post Doc Candidate, Stability of Viscoelastic Drop to Finite Perturbation/Multi-scale Simulation of Droplets on Solid Surfaces
9/17 Hugo Aerts,Ph.D.,University of Maastricht, Identification of the Radioresistant Areas Within the Tumor: Towards Dose Painting by Volumes
9/16 Amlan Chakraborty,Ph.D.,IMO Post Doc Candidate, Effects of Bidirectional Ocillatory Shear Stress on Endothelial Cell Proliferation, Morphology and Atherogenic Gene Expressions
8/26 Haley Jane Abel,Ph.D.,University of Utah, Estimating Linkage Disequilibrium by Graphical Modeling
6/24 Fang Yin, Ph.D.,IMO Postdoc Candidate, Polymer Loop Brush Simulation Study Using Monte-Carlo and Molecular Dynamics
6/15 Kieran Smallbone, D.Phil,Manchester Centre for Integrative Systems Biology, Cancelled
6/10 Trachette Jackson, Ph.D.,University of Michigan, Endothelial Cell-Targeted Anti-Cancer Therapies IMO-PSOC Seminar
6/3 Volkan Sevim, Ph.D.,IMO Post Doc Candidate, Modeling Cyclic Dynamics in Gene Regulatory Networks: Transcriptional Cell-Cycle Oscillator in Yeast
5/27 Keiran Smalley, Ph.D., Moffitt, BRAF Inhibition in Melanoma: From Response to Resistance
5/20 Eunjung Kim, Ph.D., IMO Post Doc Candidate, Mathematical Models for Matrix Mechanics and Cell-Matrix Interactions in Biological Systems
5/13 Eduardo Sotomayor, M.D., Moffitt, Targeting Histone Deacetylase 6 and 11 to Regulate Inflammation and Immune Tolerance
4/29 Craig Stevens, MD, Ph.D./Geoffrey Zhang, Ph.D., Moffitt, Deformable Image Registration and Pulmonary Ventilation Calculation Using 4D CT
4/22 Eric Haura, M.D., Moffitt, Expanding Drug And Biomarker Space Through Protein-Protein Interaction And Phosphoproteomic Networks
4/1 Virendra Kumar, Ph.D., Moffitt, Radiomics of Lung Cancer
4/1 Heather Cornnell, Ph.D., Moffitt, Measurement And Manipulation Of The Heterogeneity Of The Physical Tumor Microenvironment
4/1 Narges Kharazani Tafreshi, Ph.D., Moffitt, Indentification Of Novel Cell-Surface Targets Specific to Breast Cancer for the Non-invasive Detection of Metastatic Breast Cancer in Lymph Node
4/1 Jonathan Wojtkowski, Ph.D., Moffitt, Chronic Autophagy is a Cellular Adaptation to Tumor Acidic pH Microenvironment
3/11 Timothy J. Yeatman, M.D., Moffitt, Molecular Signatures Of Cancer
2/25 Channa de Silva, Ph.D., Department of Chemistry & Biochemistry and Bio5 Institute, University of Arizona, Images of Cleavage: Tumor Proteases In Action
2/04 Mark Robertson-Tessi, IMO Post Doc Candidate, A Mathematical Model of Tumor-Immune Interactions
1/21 Bakhti Vasiev, Ph.D., University of Liverpool, UK, Pattern Formation in Excitable Systems with Applications to Developmental Biology
2009
12/17 Dr. Jonathan Wojtkowiak, Moffitt, TBA
12/10 Dr. Philip Maini, Centre for Mathematical Biology, University of Oxford, Some mathematical models of Cancer growth
11/19 Dr. Philip Gerlee, Niels Bohr Institute, Denmark, TBA
11/16 (Monday) Dr. Peter Hinow, University of Wisconsin Milwaukee, Spatial Model of Tumor-Host Interaction: Application of Chemotherapy
11/12 Dr. Ingeborg van Leeuwen, Karolinska Insitute, Sweden, From mathematical modelling to cell biology: (1) A multiscale model for intestinal tissue renewal; and (2) The p53 pathway: complexity, oscillations, and therapeutic exploitation
11/11 (Wednesday) Dr. Carlo Maley, The Wistar Institute, TBA
10/20 (Tuesday) Dr. Kristin Swanson, University of Washington, Personalized Mathematical Oncology: Patient-Specific Mathematical Modeling of Glioma Growth and Progression
10/15 Dr. Juan Del Valle, Moffitt, Targeting Oncoproteins with Natural Product and Secondary Structure Mimetics
10/01 Dr. Robert Gatenby, Moffitt, New ideas for discussion: 1. Evolutionarily enlightened therapy 2. An ensemble model of intracellular pathways
9/17 Dr. James DeGregori, University of Colorado, Denver, Adaptive Oncogenesis: relating stem cell fittness, aging and cancer
9/10 Dr. Dmitry Gabrilovich, Moffitt, Regulation of immune responses in cancer by myeloid-derived suppressor cells
9/03 Dr. Said Sebti, Moffitt, Drug discovery at Moffitt: from chemical biology to hypothesis-driven clinical trials
8/27 Marco Scianna, Department of Mathematics, Politecnico di Torino, Italy, Individual Cell Based Models for Cell Scatter of ARO and MLP-29 Cells in Response to Hepatocyte Growth
8/27 Chiara Giverso, Department of Mathematics, Politecnico di Torino, Italy, Cellular Potts Model for Ovarian Cancer Metastasis
7/09 Dr. Scott Antonia, Moffitt, Immunotherapy Translational Research At Moffitt
7/10 Dr. Edward Flach, Dresden Technical University, Germany Motility and the cellular Potts model. Muscle development: slow twitch cell migration
6/04 Drs. Amanda Shanks, Yoonseok Kam, Ariosto Silva, Moffitt, IMO poster presentations
5/28 Dr. James Helm, Moffitt, Signaling Pathways and Outcomes in Pancreatic Cancer
5/21 Dr. Esteban Celis, Moffitt, Development of Optimized Epitope vaccines for Cancer
5/14 Dr. John Curd, Threshold Pharmaceuticals, Tumor hypoxia as a selective target for novel treatments in cancer-lessons from the development of TH-302
5/07 Dr. S. Sendhil Velan, West Virginia University, Department of Radiology, Localized Multi-DimensionalMRS: Unraveling the hidden resonances at clinical field strengths
4/30 Drs. Liping Xu, Kavindra Nath, David Basanta, Moffitt, IMO poster presentations
4/23 Dr. Gerold Bepler, Moffitt, RRM1 in lung cancer
4/24 Mr. Gibin Powathil, University of Waterloo, Canada, Modeling brain tumor: effects of microenvironment and associated therapeutic strategies
4/24 Mr. Cory Howk, Iowa State University, A mathematical model for IL6-induced differentiation of neural progenitor cells on a micropatterned polymer substrate
4/16 Dr. Jonathan Wojtkowiak, Moffitt, Autophagy: A matter of life and death
4/09 Drs. Gary V. Martinez, Arig Ibrahim Hashim, Prasanta Dutta, Moffitt, IMO poster presentations
4/02 Dr. P. K. Burnette, Moffitt, T cell homeostatsis in Bone Marrow Failure Syndromes
3/19 Dr. Virendra Kumar, Moffitt, Magnetic resonance spectroscopy and imaging in prostate cancer
3/12 Dr. Peter Thelwall, Newcastle University, UK, Imaging oxidative stress defences with MRI
3/05 Dr. Amanda Baker, University of Arizona, Thioredoxin-interacting protein as a potential target for pancreatic cancer therapy
2/26 Dr. Ed Seto, Moffitt, The Biology of Histone Deacetylases
2/19 Dr. Anna Giuliano, Moffitt, The Natural History of Human Papillomavirus Infection in Men
2/18 Dr. Emi Shudo, Los Alamos National Laboratory, Hepatatis C virus kinetics during treatment with pegylated interferon alfa-2b. A model that allows for time-varying drug effectiveness. & Dynamic optimization of the immune reaction against virus/bacteria infection
2/12 Dr. Yoonseok Kam, Moffitt, In vitro cancer migration-invasion assay design driven by mathematical models
2/05 Dr. Thomas Sellers, Moffitt, Approaches to determine ovarian cancer susceptibility
1/29 Samuel E. Day, University of Cambridge & NIH, DNP hyperpolarized 13C-MRI: an approach to study enzyme function using magnetic resonance spectroscopy and imaging
1/22 Dr. Eric Haura, Moffitt, Using shotgun phosphoproteomics to discern tyrosine kinase signaling in cancer
1/21 Dr. Hugo Aerts, University of Maastricht, Computer assisted theragnostics: an individualized decision support system
1/09 Natasha Kaleta Martin, University of Oxford, Biocarbonate therapy: from mice to humans with mathematical models
1/08 Dr. John Koomen, Moffitt, Cancer proteome cataloging and quantitative network analysis
2008
12/18 Dr. William Dalton, Moffitt, Novel targets to inhibit and reverse drug resistance in hematologic malignances
12/11 Dr. Javier Torres-Roca, Moffitt, System biology modeling of the radiosensitivity network
12/04 Dr. Ami Radunskaya, Pomona College, Mathematical models of tumor-immune interactions
11/20 Dr. David Morse, Moffitt, Choline as a biomarker for breast cancer diagnosis and therapeutic response
11/13 Dr. Simon Hayward, Vanderbilt University, Cellular interactions andprostate cancer progression
11/06 Dr. Keiran Smalley, Moffitt, Using 3D cell culture models to bring new insightsto cancer biology
10/30 Dr. Kasia Rejniak, Moffitt, IBCell model in cancer development andtreatment
10/23 Dr. Gerard Ostheimer, MIT, Data driven modeling of cellular senescence andapoptosis after DNA damage
10/16 Dr. Lori Hazlehurst, Moffitt, The bone marrow microenvironment contributestowards resistance to BCR-ABL inhibitors in CML
10/09 Dr. Philip Tofilon, Moffitt, The microenvironment and glioblastoma radiosensitivity
9/25 Dr. Alexander Anderson, Moffitt, Microenvironment driven invasion: a multiscale multimodel investigation
9/18 Dr. Robert Gilles, Moffitt, Acid-mediated invasion and bicarb treatment
9/11 Dr. David Basanta, Moffitt, Evolutionary game theory approaches to cancer modeling
9/04 Dr. Ariosto Silva, Moffitt, Adaptive therapy : an alternative cancer treatment